rs11942466
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs11942466(A;A) |
Make rs11942466(A;C) |
Make rs11942466(C;C) |
Reference | GRCh38.p7 38.3/151 |
Chromosome | 4 |
Position | 74556361 |
Gene | LOC107986229 |
is a | snp |
is | mentioned by |
dbSNP | rs11942466 |
dbSNP (classic) | rs11942466 |
ClinGen | rs11942466 |
ebi | rs11942466 |
HLI | rs11942466 |
Exac | rs11942466 |
Gnomad | rs11942466 |
Varsome | rs11942466 |
LitVar | rs11942466 |
Map | rs11942466 |
PheGenI | rs11942466 |
Biobank | rs11942466 |
1000 genomes | rs11942466 |
hgdp | rs11942466 |
ensembl | rs11942466 |
geneview | rs11942466 |
scholar | rs11942466 |
rs11942466 | |
pharmgkb | rs11942466 |
gwascentral | rs11942466 |
openSNP | rs11942466 |
23andMe | rs11942466 |
SNPshot | rs11942466 |
SNPdbe | rs11942466 |
MSV3d | rs11942466 |
GWAS Ctlg | rs11942466 |
Max Magnitude | 0 |
? | (A;A) (A;C) (C;C) | 28 |
---|---|---|
|
[PMID 29771169] Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial.